Wan Yee Lau
- Hepatology top 0.02%
- Hepatocellular Carcinoma Treatment and Prognosis 254
- Liver Disease and Transplantation 67
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research 76
- Surgery top 0.1%
- Cholangiocarcinoma and Gallbladder Cancer Studies 141
- Organ Transplantation Techniques and Outcomes 37
- Cancer Research top 0.5%
- Epidemiology top 0.2%
- Liver Disease Diagnosis and Treatment 118
- Hepatitis B Virus Studies 43
-
- Gallbladder and Bile Duct Disorders 44
- Co-authors
- Eric C. H. LaiPaul B.S. LaiRong GuoMin-Shan ChenMengchao WuYa-Qi ZhangXiao-Jun LinKa Lau Leung
- Cited by
- HepatologyOncologySurgery
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Wan Yee Lau
427 papers receiving 18.7k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Hepatology 10.8k
- Oncology 5.4k
- Surgery 8.0k
- Cancer Research 2.6k
- Epidemiology 5.7k
Countries citing papers authored by Wan Yee Lau
This map shows the geographic impact of Wan Yee Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Yee Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Yee Lau more than expected).
Fields of papers citing papers by Wan Yee Lau
This network shows the impact of papers produced by Wan Yee Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Yee Lau. The network helps show where Wan Yee Lau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wan Yee Lau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 18 | |
| 5 | TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching studybreakdown → | 2023 | 71 |
| 6 | 2022 | 5 | |
| 7 | 2022 | 23 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 48 | |
| 10 | 2019 | 35 | |
| 11 | 2018 | 0 | |
| 12 | 2016 | 4 | |
| 13 | 2016 | 89 | |
| 14 | Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trialbreakdown → | 2012 | 369 |
| 15 | 2012 | 26 | |
| 16 | 2010 | 2 | |
| 17 | 2005 | 467 | |
| 18 | THE BRISBANE 2000 TERMINOLOGY OF LIVER ANATOMY AND RESECTION | 2002 | 51 |
| 19 | Case 18. Presentation | 1997 | 1 |
| 20 | 1990 | 11 |
About Wan Yee Lau
Wan Yee Lau is a scholar working on Hepatology, Surgery and Oncology, having authored 440 papers that have together received 19.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (254 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (141 papers), Liver Disease Diagnosis and Treatment (118 papers), Pancreatic and Hepatic Oncology Research (76 papers), Liver Disease and Transplantation (67 papers), Gallbladder and Bile Duct Disorders (44 papers), Hepatitis B Virus Studies (43 papers) and Organ Transplantation Techniques and Outcomes (37 papers). The work is most often cited by research in Hepatology (10.8k citations), Oncology (5.4k citations) and Surgery (8.0k citations). Wan Yee Lau has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Eric C. H. Lai, Paul B.S. Lai, Rong Guo, Min-Shan Chen, Mengchao Wu, Ya-Qi Zhang, Xiao-Jun Lin, Ka Lau Leung, Jin-Qing Li and Simon C.H. Yu. Their work appears in journals such as The Lancet, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.